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Objective: Endovascular aortic aneurysm repair (EVAR) is widely used for the treatment of abdominal aortic aneurysms.
Complications secondary to EVAR are also treated with endovascular techniques. When this is not applicable, open
surgical repair is mandatory. This study aims to present our experience in open surgical repair after failed EVAR.
Methods: Within the period from 2004 through 2013, 18 patients (17 men; mean age, 73.9 years) were operated on
because of EVAR failure due to persistent type II endoleak (n [ 10), type I or III endoleak (n [ 3), mixed-type
endoleaks (n [ 2), stent graft thrombosis (n [ 2), and aortoenteric ﬁstulae (n [ 1). Stent grafts used for EVAR were
Zenith (n [ 8), Talent (n [ 4), Excluder (n [ 4), and Anaconda (n [ 2).
Results: Mean time interval between EVAR and open conversion was 36 months (range, 2-120 months). Fifteen (83.3%)
operations were elective, and three (16.7%) were urgent due to aneurysm rupture (n[ 2) and aortoenteric ﬁstula (n[ 1).
Six (33.3%) patients with type II endoleak were treated with simple ligation of the culprit vessels, without aortic clamping
and stent graft explantation. In six (33.3%) patients, the stent graft was partially removed except from the segment
attached to the proximal neck, while in ﬁve (27.8%) patients, complete removal of the stent graft was necessary. Finally, in
one patient, with type III endoleak, a hybrid endovascular and open repair was performed. Clamping of the aorta was
necessary in 12 (66.7%) patients (infrarenal, n [ 10 or suprarenal, n [ 2). Overall operative mortality was 5.6%.
Postoperative complications included one abdominal wall defect requiring surgical revision and paroxysmal atrial
ﬁbrillation both in the same patient, and one case of pulmonary infection, requiring prolonged intubation and intensive
care unit stay for 6 days.
Conclusions: Late open conversion after failed EVAR remains challenging. Avoidance of aortic cross-clamping and if
possible, partial or total preservation of the stent graft may improve outcomes in terms of operative mortality and
morbidity. Elective operations seem to be associated with better outcomes, prompting thus for close follow-up of EVAR
patients and early decision for conversion if other options are doubtful. (J Vasc Surg 2014;59:291-7.)Endovascular aortic aneurysm repair (EVAR) has
changed the management of abdominal aortic aneurysms
(AAAs) during the last 2 decades. More than half of the
patients are nowadays treated with EVAR, and in many
centers, elective open AAA repair is reserved only for rare
cases anatomically unsuitable for EVAR.1 EVAR offers
a clear beneﬁt in terms of perioperative morbidity and
mortality over open repair, but it is also associated with
increased rates of late secondary reinterventions.2 Indeed,
although improvements in endovascular technology and
physicians’ growing experience have led to better EVAR
results, late complications after EVAR still remain an issue.
Most of the time, these can be successfully treated with
endovascular means, but open conversion can still be
required in 0% to 9% of cases,3-10 with a morethe First Department of Surgerya and Second Department of Prope-
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Collaborators on Stent Graft Techniques for Aortic Aneu-
rysm Repair (EUROSTAR) Registry.11 Indications for
secondary conversion vary and include endoleaks not
amenable to endovascular management, stent graft infec-
tion, aneurysm rupture, and stent graft thrombosis.12
Surgical reintervention following EVAR is considered
to be more demanding compared with primary open
repair.13 The pre-existing stent graft adds more challenges
to the procedure and can lead to increased perioperative
morbidity and mortality.14-17 In the present study, we
review our experience on late open conversions after failed
EVAR, aiming to highlight technical factors that may
improve outcomes.
METHODS
All consecutive patients with AAAs that were treated
with late open conversion after previous failed EVAR
within the period of May 2004 through January 2013 in
a single-center institution were included in this study.
Data were prospectively collected in a database and were
retrospectively analyzed for this study.
Late open conversion was deﬁned as an open surgical
procedure performed at >30 days after the initial EVAR
operation. Patients were excluded from analysis if conver-
sion was performed at the time or within 1 month of the291
Table I. Preoperative patient characteristics
Comorbidity/risk factor Patients, No. (%)
Coronary artery disease 8 (44)
Hypertension 13 (72)
Chronic obstructive pulmonary disease 5 (28)
Smoking (current or past) 10 (56)
Diabetes mellitus 4 (22)
Hypercholesterolemia 10 (56)
Serum creatinine >100 mmol/L 6 (33)
Previous stroke/transient ischemic attack 3 (17)
Hostile abdomen 1 (6)
Antiplatelet therapy 12 (67)
Anticoagulant therapy 1 (6)
Table II. Summary of indications for late open conversion
Treatment indication Patients, No. (%)
Type II endoleak þ sac enlargement (1 rupture) 10 (56)
Type III endoleak 1 (5.6)
Type Ia and II endoleak 1 (5.6)
Type Ia and Ib endoleak 1 (5.6)
Type Ia endoleak þ rupture 1 (5.6)
Stent graft thrombosis þ type II endoleak 1 (5.6)
Aortoenteric ﬁstula 1 (5.6)
Limbs’ thrombosis 1 (5.6)
Type Ib endoleak 1 (5.6)
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stent graft removal were included. In the latter case,
open surgery was performed to repair endoleaks without
explant of the stent graft. Preoperative collected and
analyzed data included patient demographics, previous
endovascular reinterventions, indication for open conver-
sion, stent graft type, and time frame between the initial
EVAR and open conversion. The physical status of all
patients was assessed preoperatively with the American
Society of Anesthesiologists (ASA) score. The intraopera-
tive details were also reviewed including the surgical
approach, use of aortic cross-clamping, stent graft removal
or not, estimated blood loss, and operative time. Postoper-
ative analyzed variables included major perioperative
(<30 days) complications, length of intensive care unit
(ICU) and hospital stay, and 30-day mortality.
SPSS for Windows (version 17.0; SPSS Inc, Chicago,
Ill) was used for statistical analysis. Continuous variables
are presented as mean (range) and categorical variables as
percentages.
RESULTS
Patients. BetweenMay 2004 and January 2013, a total
of 895 AAA repairs, comprised of 453 open procedures
and 442 EVARs, were performed in our institution. A total
of 18 patients (17 male; mean age, 73.9 years; range, 55-
91 years) required late open conversion after failed previous
EVAR during this period. Thirteen (72.2%) patients were
classiﬁed as ASA III, four (22.2%) patients as ASA II, and
one (5.6%) patient as ASA IV. Patients’ comorbidities are
shown in Table I. In eight patients (44.4%), EVAR had
been performed in our hospital, and 10 patients (55.6%)
had been operated upon elsewhere.
Previous stent grafts and current aneurysm char-
acteristics. Mean time interval from previous EVAR to
open conversion was 36 months (range, 2-120 months).
Seventeen of the initially implanted stent grafts were bifur-
cated, and one was aorto-uni-iliac. Eight (44.4%) patients
were previously treated with a Zenith (seven bifurcated,
one aorto-uni-iliac) stent graft (Cook Inc, Bloomington,
Ind), four (22.2%) with a Talent (Medtronic World
Medical, Sunrise, Fla), four (22.2%) with an Excluder(W. L. Gore & Associates, Flagstaff, Ariz), and two
(11.1%) with an Anaconda (Vascutek, Inchinnan, Scotland,
UK). Mean maximal AAA diameter was 73 mm (range, 61-
120 mm).
Indications for late conversion. The most frequent
reason for elective open reintervention was persistent type
II endoleak with aneurysm sac enlargement (n ¼ 10;
56%). Other indications included type Ia, type Ib and
type III endoleaks, or a combination of them. One patient
was operated on due to total stent graft thrombosis and
concomitant type II endoleak with aneurysm sac enlarge-
ment, and one was operated on because of both limbs’
thrombosis due to excessive kinking. Fifteen (83.3%)
patients were operated on electively, and three (16.7%)
on an emergency basis due to aneurysm rupture in two
cases and aortoduodenal ﬁstula in one. The ﬁrst patient
with rupture had not complied with follow-up and pre-
sented 5 years after EVAR, with free rupture and hypo-
volemic shock due to a large type Ia endoleak. The second
patient had an unremarkable follow-up without any
endoleak the ﬁrst 2 years after EVAR. He did not have any
further follow-up and presented 2 years later with a retro-
peritoneal rupture due to a new-onset type II endoleak
originating from the inferior mesenteric artery. Finally, one
patient required conversion for an aortoduodenal ﬁstula
9 months after EVAR and subsequent proximal cuff
placement for type Ia endoleak. Table II summarizes the
indication of conversion in the whole patient cohort.
In our institution, we preferentially treat EVAR compli-
cations with endovascular means. Open conversion is
reserved for those patients that are not amenable to endovas-
cular revision, or if such an approach has already been
attempted and failed. Ruptured/urgent cases are also prefer-
entially treated with open conversion. Especially for type II
endoleaks, we lately tend to more liberally suggest direct
open conversion aiming for graft preservation and no aortic
cross-clamping as a more likely deﬁnite treatment option. In
this series, seven patients (46.7%) of the elective group had
undergone secondary endovascular reinteventions before
ending up with open conversion. These included multiple
attempts of coil embolization for type II endoleak in four
patients, limb graft extension for type Ib endoleak in two,
and stent graft relining with a proximal cuff and two limb
grafts for suspected endotension in one patient. The
Fig 1. Aneurysm sac opening without aortic cross-clamping (A and B) and ligation of the culprit lumbar artery with
complete preservation of the stent graft (C). Note the proximal aortic clamp that is kept open in position to be used in
case of bleeding (blue arrows).
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a previous endovascular attempt either because they were
not good candidates for endoluminal correction due to jux-
tarenal aneurysm anatomy (n¼ 2), aortoduedenal ﬁstula and
infection (n ¼ 1), severe limb-graft kinking (n ¼ 1),
complete stent graft thrombosis (n ¼ 1) and rupture (n ¼
2), or due to their willingness for a most likely deﬁnite treat-
ment (n ¼ 4).
Operative details. Sixteen patients (88.9%) were oper-
ated on through a transperitoneal approach, one (5.6%)
through a right retroperitoneal approach, and one (5.6%)
with right transverse incision for concomitant right partial
nephrectomy. Mean operative time was 200 minutes
(range, 90-280 minutes), and the mean estimated blood
loss was 1200 mL (range, 300-3300 mL).
In six (33.3%) patients with type II endoleak and
ongoing sac enlargement, no aortic clamping wasperformed, and the stent graft was completely preserved.
Four of these patients had previously undergone two or
more transarterial coil embolization attempts of the culprit
arteries without success in the long term and were there-
fore ﬁnally subjected to open conversion. Two patients
underwent open conversion directly, without any endovas-
cular attempt, due to their willingness for a more likely
deﬁnite treatment.
In one case, the IMA was clip-ligated externally at its
origin through a right transverse incision for right partial
nephrectomy, and in the remaining ﬁve cases, including
one patient with rupture, the aneurysm sac was opened
without aortic cross-clamping, and the culprit lumbar
oriﬁces were ligated from inside the sac, without removal
of the stent graft (Fig 1). Opening the sac and ligating
the culprit vessels from inside rather than laparoscopic or
via laparotomy ligation from outside the sac was our
Fig 2. Partial removal of the stent graft. A proximal rim (arrow) is
preserved and is included together with the aortic wall in the
suture line of the proximal anastomosis.
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all back-bleeding vessels were identiﬁed and ligated. The
aneurysm sac was again sutured only after complete hemo-
stasis was achieved and no more back-bleeding (even
minimal) was evident. In one of the above patients, an
additional endovascular limb bridging was performed due
to threatened limb dislodgement noticed in preoperative
imaging (plain X rays). Despite avoidance of aortic cross-
clamping, the proximal aortic neck was carefully exposed
in all these cases to ensure prompt clamping in case of stent
graft dislodgment after sac opening during maneuvers for
lumbar artery ligation.
In six (33.3%) patients, partial removal of the stent graft
was performed. In three of themwith sac enlargement due to
type II endoleak, the stent graft was dislodged after sac
opening, during maneuvers for lumbar artery ligation from
inside the sac, and inevitably was cut and removed under
infrarenal clamping. The proximal part of the stent graft
that was attached to the aneurysm neck was maintained,
since it was found to be well incorporated into the aortic
wall, and we did not want to risk denudation/laceration of
the juxtarenal aorta during complete removal attempts
(Fig 2). A conventional tube or bifurcated Dacron graft
was suturedwith 3.0 Prolene, including both themaintained
part of the stent graft and the aortic wall in the suture line. In
one patient with type II endoleak and intraoperative ipsilat-
eral limb graft dislodgement, we cut and removed the dis-
lodged limb under proximal limb graft clamping and
bridged it to the common iliac artery with a short Dacron
bypass graft. In one patient with limbs thrombosis due to
kinking, the distal stent graft was removed under infrarenal
clamping, and the aorta was reconstructed with a bifurcated
Dacron graft sutured proximally to the preserved stent graft
part. Finally, in one patient with a totally thrombosed
Anaconda stent graft and a type II endoleak, the stent graft
was partially removed under suprarenal clamping, preserving
a proximal rim due to dense incorporation in the atrophic
aortic wall. Patent lumbar arteries were ligated, and aDacron
aorto-bi-iliac graft was accomplished.In ﬁve (27.8%) patients, complete stent graft removal
was considered necessary due to inadequate proximal
and/or distal sealing or infection. Indications for surgery
in these ﬁve patients were endoleak type Ia and II, type
Ia and Ib, type Ib, aneurysm rupture, and aortoduodenal
ﬁstula, respectively. Infrarenal clamping was performed in
four cases, while in one case, suprarenal clamping was
required. Aortic reconstruction after stent graft removal
was performed with a tube and a bifurcated graft in two
cases each and aortic ligation and axillo-bifemoral bypass
in one case with infection due to aortoduodenal ﬁstula.
Finally, in one (5.6%) patient, with type III endoleak,
a hybrid repair was performed, consisting of open catheter-
ization of the contralateral gate and the dislodged contra-
lateral limb under infrarenal proximal aortic control and
deployment of a bridging stent graft, under ﬂuoroscopy.
Overall, proximal aortic clamping was required in 12
(66.7%) patients, infrarenal in 10 (55.6%), and suprarenal
in 2 (11.1%) cases.
In this cohort, two distinguished patterns of aortic wall
reaction were observed: (1) inﬂammatory response (n ¼ 6;
33.3%); and (2) atrophy of the aortic wall (n ¼ 3; 16.7%).
In nine (50%) patients, the aortic wall was found to be
unaffected intraoperatively.
Postoperative mortality and morbidity. There was
one perioperative death in this series, in a patient operated
on urgently due to aneurysm rupture, accounting for an
overall 30-day mortality of 5.6%. This patient had a large
type Ia endoleak and presented with free rupture and
hypovolemic shock. He underwent complete stent graft
explantation and aortic reconstruction with a tube graft
but succumbed to multiple organ failure 1 day later.
Postoperative complications included one abdominal wall
defect requiring surgical revision and a paroxysmal atrial
ﬁbrillation, both in the same patient. One patient, who
suffered from acute respiratory distress syndrome, required
intubation and an ICU stay for 6 days. Overall, the need
for ICU stay was 2/18 (11.1%). Mean hospital stay was
7.8 days (range, 3-13 days). There were no late compli-
cations or deaths in a mean follow-up of 25.7 months
(range, 2-60 months).
DISCUSSION
Improvements in endovascular technology and
imaging equipment along with physicians’ increasing expe-
rience have led to improved outcomes of EVAR during the
last decade. Nevertheless, the need for late reinterventions
after EVAR persists. Although many complications after
EVAR can be successfully managed with secondary endo-
vascular interventions,18 open conversion is, in some cases,
unavoidable. Rates of late open conversion after failed
EVAR vary among the published series from 0% to
9%.3,7-12,14
Open surgical reintervention after failed EVAR is associ-
ated with unique technical challenges. Dissection can be
cumbersome due to periaortic inﬂammation that is often
observed after endovascular graft implantation.10 The pre-
existing stent graft and the additional devices possibly placed
Table III. Summary of series reporting late open
conversion after endovascular aneurysm repair (EVAR)
Author (year)
Late
conversions,
No.
Mean time
after
EVAR,
months
Elective/
urgent
30-day
mortality, %
(elective/
urgent/total)
Lipsitz (2003) 11 30 4/11 25/14/18
Terramani
(2003)
9 24 7/2 NR/NR/11
Verhoeven
(2004)
9 41 8/1 0/0/0
EUROSTAR
(2004)
26 32 20/6 NR
Kong (2005) 16 34 15/1 0/100/6.5
Lifeline
Registry
(2005)
28 NR NR/NR 0/0/0
Verzini (2006) 29 33 25/4 0/0/0
Brewster
(2006)
20 31 15/5 13/40/20
Tiesenhausen
(2006)
26 42 20/6 0/50/14
Jimenez
(2007)
12 26.5 NR/NR 0/0/0
Kelso (2009) 25 33.3 NR/NR 6.4/50/17
AURC (2009) 20 41 12/8 8.3/25/15
Pitoulias
(2009)
39 NR 34/5 8.8/20/10.2
Nabi (2009) 12 44.7 12/0 8.3/NA/8.3
Brinster
(2011)
21 33.4 16/5 0/0/0
Chaar (2012) 44 45 19/25 8/28/18
Present series 18 36 15/3 0/33/5.6
NA, Not applicable; NR, relative information could not be retrieved.
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ties to achieve proximal or distal vascular control. Suprarenal
aortic clamping may be frequently required.10,19 Complete
explantation of the stent graft, especially of those with supra-
renal ﬁxation, can also be challenging due to dense incorpo-
ration to the aortic wall.15 Finally, patients after failed EVAR
represent most likely a high-surgical-risk patient cohort,
given that open surgery was avoided as primary treatment
option for their AAA.
The above factors frequently result in higher operative
mortality and morbidity rates of open conversion compared
with primary open AAA repair. May et al12 reported a 17%
mortality rate and a similarly high incidence of renal failure
requiring hemodialysis after late open conversion. Other
authors have reported mortality rates up to 20%, in elective
cases requiring supraceliac clamping.9 The EUROSTAR
registry, which reﬂects a large multicenter experience,
showed a 24% mortality rate after late surgical conver-
sion.11 Finally, a systematic review, with a total of 8304
patients, revealed a cumulative mean mortality of 23%,20
and a more recent one showed a mortality of 10%.21
Table III summarizes the previously published series
reporting late conversion after failed EVAR.
Our results compare favorably with the above rates.
Operative mortality was 5.6%. The postoperative courseof our patients was generally uneventful, and this is re-
ﬂected in the fact that only 11.1% of the patients needed
an ICU stay and that there was a relatively short hospital
stay. These results may be attributed to several factors.
Clamping of the infrarenal aorta that contains a stent
graft can theoretically be cumbersome, resulting in stent
graft damage or incomplete proximal control. In two
patients of this series, we felt that initial infrarenal clamping
would not be completely hemostatic, which led us to
proceed to suprarenal clamping as described above. Other-
wise, no case of inadvertent stent graft damage/crashing
due to infrarenal clamping was observed. Nevertheless,
our patient cohort is too small to advocate general safety
of infrarenal aortic clamping upon existence of a stent graft.
Proximal aortic clamping was avoided in 33.3% of the
patients, while temporary suprarenal aortic clamping was
required only in 11.1%. No patient required supraceliac
aortic clamping. The physiological consequences of aortic
cross-clamping are well known; prolonged clamping time
results in severe renal ischemia, aortic clamp injury, and
metabolic disorders.15 Older multimorbid patients in
particular, who represent the most common patient proﬁle
requiring late conversion, are more vulnerable to the phys-
iologic effects of aortic cross-clamping. Suprarenal clamp-
ing can have an even greater impact, and is much less
tolerated compared with infrarenal clamping, resulting in
signiﬁcant increase in operative morbidity and mortality.15
Our results indicate that open surgical repair of isolated
type II endoleaks can be safely performed without aortic
cross-clamping and should be attempted whenever
possible. This is in line with the recently published series
by Chaar et al.17 Such a strategy additionally results in
shorter operative times, a factor that needs also consider-
ation when treating old high-risk patients.
Complete stent graft explantation was required and
performed only in 27.8% of the patients. In the remaining
cases, the whole or a part of the stent graft was preserved.
This could have also contributed to the good results
observed herein. Indeed, partial stent graft preservation
has been associated with better operative outcomes.22 We
routinely follow a strategy of partial stent graft removal in
these cases, and we try to preserve proximal and, in some
cases, distal parts of the stent graft when these seem to
be well incorporated and seal adequately. The anastomoses,
both proximally and distally, can be performed with inclu-
sion of the aortic wall and the stent graft remnant, and this,
in our opinion, contributes to a more secure and less prone
to bleeding anastomosis. Besides, such a strategy minimizes
the risk of severe aortic wall injury during stent graft
explantation maneuvers. The latter can result in disastrous
complications proximally at the visceral aorta, but also
distally, where denudation of the arterial wall after stent
graft explantation can make the construction of the anasto-
moses problematic.
Chronic reaction of the aortic wall in the presence of
a stent graft differs among patients. As already stated,
herein we did observe two distinguished patterns of aortic
wall reaction: (1) inﬂammatory response; and (2) atrophy
JOURNAL OF VASCULAR SURGERY
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atrophy) can make the operation more challenging, posing
difﬁculties in initial dissection of the aorta and later during
stent graft explantation if needed. Partial preservation of
a stent graft cuff at the sealing zones proximally and distally
is therefore recommended when it seems to be well incor-
porated and seal adequately.
Large series in the literature indicate that lumbar
artery embolization carries a low midterm success rate,
and most patients require multiple reinterventions to treat
type II endoleaks.23 Gallagher et al reported a 17% success
rate of the initial intervention at 2 years, while repeated
embolization attempts resulted in a 40% secondary success
rate. Twenty-four percent of the patients continued to
have endoleak despite multiple reinterventions.24 Sarac
et al, in a retrospective review of patients treated with
embolization with glue, coils, glue and coils, and Gelfoam
due to type II endoleak showed a 5-year freedom from
second embolization of 76% (95% conﬁdence interval,
66%-86%) and freedom from sac expansion >5 mm of
44% (95% conﬁdence interval, 30%-50%). The authors
concluded that a signiﬁcant number of patients require
multiple reinterventions, and at 5 years, many patients
continue to experience sac growth. In line with the above,
Aziz et al concluded that percutaneous endovascular
intervention, either transcathter or translumbar, for type
II endoleak does not inhibit aneurysm sac growth rate,
and most of the patients demonstrate persistent/recurrent
endoleak.25 The present experience shows that isolated
type II endoleaks associated with sac enlargement can
be frequently repaired with simple lumbar artery ligation
and complete stent graft preservation, without the need
for aortic cross-clamping. This “minimal” type of open
conversion has very good results and is well tolerated
even by old high-risk patients. Based on that, we have
lately become more aggressive, tending to offer an early
conversion to patients with type II endoleak, without
waiting for endovascular techniques with uncertain
long-term efﬁcacy.
Opening the aneurysmal sac and ligating the culprit
lumbar arteries from within the sac can occasionally result
in stent graft dislodgment and the need for partial or
complete stent graft removal. This happened in three of
our cases, whereas in ﬁve patients, we were able to ligate
the lumbar arteries without stent graft dislodgment, which
allowed for complete graft preservation. Certainly, dislodg-
ment of the stent graft cannot be excluded after sac
opening, and one has to be ready to confront such an event
upon occurrence. Clear exposure of the aortic neck before
sac opening is therefore strongly recommended to enable
prompt clamping upon stent graft dislodgment. Most of
the time, however, the operation can be successfully
accomplished without stent graft dislodgment, and the
patient has important beneﬁts (short operation time, avoid-
ance of aortic cross-clamping, deﬁnite treatment in contrast
to “blind” ligation of culprit vessels without opening the
sac, etc).There was one death in this series. This patient was lost
to follow-up and suffered a free aortic rupture secondary to
a large type Ia endoleak. He presented to our emergency
department in hypovolemic shock and was immediately
transferred to the operating room. Although we were
able to ﬁnish the procedure in due time and with minimal
blood loss, the patient succumbed the following day due to
multiple organ failure. The second patient that presented
with rupture was free of endoleak for the ﬁrst 2 years after
EVAR, but was thereafter lost to follow-up and presented
2 years later with a retroperitoneal rupture due to a type
II endoleak originating from the inferior mesenteric artery.
Both these cases highlight the need for continued long-
term surveillance of patients treated with EVAR, even in
the absence of any signs of endoleak. Our surveillance
protocol for stable EVAR patients that are considered to
be endoleak-free consists of biannual duplex ultrasound
and abdominal X ray. We proceed to computed tomog-
raphy angiography and occasionally digital subtraction
angiography if signs of endoleak and/or aneurysm sac
enlargement are detected in ultrasound or stent graft
migration or dislodgement is seen in the X ray.
Thirteen (72.2%) patients were on antiplatelet/antico-
agulant medications preoperatively (Table I). This may
have also contributed to the persistence of the observed
endoleaks, although no safe conclusions can be drawn
with such a small patient cohort.26 Bobadilla et al have
shown that anticoagulation with warfarin was linked with
increased risk for type II endoleak development after
EVAR, while Aoki et al27 reported a correlation between
multiagent antiplatelet therapy and lack of aneurysm
shrinkage 6 months after EVAR. More recently and in
contrast to the above, Johnson et al28 suggested that oral
chronic anticoagulation treatment with warfarin does not
affect the incidence of endoleaks after EVAR. Obviously,
further investigation is needed to clearly deﬁne the poten-
tial risk of antiplatelet/anticoagulant medications on endo-
leak persistence.
This series does not provide reliable information
regarding the incidence of late open conversions after
EVAR. We do follow our patients strictly and are aware
of their complications in about 85% of them. Nevertheless,
the patient cohort presented herein also includes patients
that were primarily treated elsewhere, making it thus
impossible to estimate the real proportion of EVAR
patients needing late conversion.
The number of patients treated with EVAR is
increasing. This, in combination with a more liberal use
of EVAR devices, even outside the instructions for use,29
and the younger age of treated patients, will likely lead to
an increased need for late open conversions after EVAR.
Modiﬁcations of the current techniques and careful
tailoring and planning of the procedure according to
each individual’s anatomic and risk proﬁle may result in
better outcomes. Despite current endovascular enthusiasm,
the vascular surgery community should also focus on
improving open surgery results after EVAR.
JOURNAL OF VASCULAR SURGERY
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Late open conversion after failed EVAR remains chal-
lenging. Stent graft preservation, aortic clamp avoidance,
and careful operative planning seem to improve results in
these difﬁcult cases. Elective conversions seem to be associ-
ated with better outcomes. Close follow-up of EVAR
patients is therefore of pivotal importance in order to diag-
nose complications early and treat them on an elective
basis.
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